Australia markets closed

Vertex Pharmaceuticals Incorporated (0QZU.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
444.25+5.24 (+1.19%)
At close: 07:12PM BST
Full screen
Previous close439.01
Bid0.00 x 0
Ask0.00 x 0
Day's range440.00 - 444.39
52-week range290.87 - 446.29
Avg. volume2,907
Market cap1.142B
Beta (5Y monthly)0.39
PE ratio (TTM)0.47
EPS (TTM)9.48
Earnings date30 July 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Jennifer Schneider Elected to Vertex Board of Directors

    BOSTON, May 15, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jennifer Schneider, M.D., M.S., has been elected to its Board of Directors as an independent director. Dr. Schneider has more than two decades of experience in the health care industry as a physician, scientist and health care executive. She co-founded and serves as Chief Executive Officer of Homeward Health, a company committed to rearchitecting the delivery of health and care for nearly 60 million Ame

  • Investor's Business Daily

    Vertex Stock Hit All-Time High, Paused, Rising Again

    A Relative Strength Rating upgrade for Vertex stock shows improving technical performance. Will it continue?

  • Zacks

    Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock

    The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.